HLA-C and neoplasm: Nevertheless, to more definitively explore the role of IDO in negative regulation of cross-primed TCD8 responses, we injected WT and IDO−/− B6 (H-2b) mice with the T Ag+, MHC-mismatched (H-2d) kidney epithelial tumor cell line KD2SV.